Skip to main content
Steven Boas, MD, Pediatric Pulmonology, Northfield, IL, Ann & Robert H. Lurie Children's Hospital of Chicago

StevenRussellBoasMD

Pediatric Pulmonology Northfield, IL

Cystic Fibrosis Pulmonology, Pediatric Asthma Pulmonology, Pediatric Bronchoscopy

Clinical Professor, Pediatrics, Northwestern University Medical School

Dr. Boas is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Boas' full profile

Already have an account?

Summary

  • Specializing in Sports Pulmonology

Education & Training

  • UPMC Medical Education
    UPMC Medical EducationFellowship, Pediatric Pulmonology, 1992 - 1995
  • Nassau University Medical Center
    Nassau University Medical CenterResidency, Pediatrics, 1990 - 1992
  • Children's Hospital/Boston Medical Center
    Children's Hospital/Boston Medical CenterInternship, Pediatrics, 1989 - 1990
  • Stony Brook University Health Sciences Center School of Medicine
    Stony Brook University Health Sciences Center School of MedicineClass of 1989

Certifications & Licensure

  • IL State Medical License
    IL State Medical License 1995 - 2026
  • IN State Medical License
    IN State Medical License 2005 - 2025
  • PA State Medical License
    PA State Medical License 1992 - 1996
  • NY State Medical License
    NY State Medical License 1992 - 1992
  • American Board of Pediatrics Pediatric Pulmonology
  • National Board of Physicians and Surgeons Pediatrics

Awards, Honors, & Recognition

  • Most Compassionate Doctor American Registry
  • Fellow (FAAP) American Academy of Pediatrics

Publications & Presentations

PubMed

Press Mentions

  • 1st CF Patient Screened for Phase 2 Trial of Adrulipase to Treat EPI
    1st CF Patient Screened for Phase 2 Trial of Adrulipase to Treat EPIFebruary 7th, 2023
  • First Wave BioPharma Announces First Patient Screened for Phase 2 SPAN Adrulipase Trial in Cystic Fibrosis
    First Wave BioPharma Announces First Patient Screened for Phase 2 SPAN Adrulipase Trial in Cystic FibrosisFebruary 2nd, 2023
  • First Sites Selected for Enhanced Adrulipase Formulation Phase 2 Trial
    First Sites Selected for Enhanced Adrulipase Formulation Phase 2 TrialDecember 8th, 2022
  • Join now to see all

Professional Memberships

Hospital Affiliations